The pathophysiology of CAPS is multifactorial and complex, with aPLs triggering pro-inflammatory activity of endothelial cells and release of pro-inflammatory cytokines (ie. interleukin-6) that promote a pro-coagulant state and inhibit fibrinolytic pathways [1,6]. Here, IL6 is linked to cryopyrin-associated periodic syndrome.